Jeffrey S. Barrett

6.8k total citations
192 papers, 5.0k citations indexed

About

Jeffrey S. Barrett is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Molecular Biology. According to data from OpenAlex, Jeffrey S. Barrett has authored 192 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Pediatrics, Perinatology and Child Health, 40 papers in Pharmacology and 32 papers in Molecular Biology. Recurrent topics in Jeffrey S. Barrett's work include Pharmaceutical studies and practices (46 papers), Antibiotics Pharmacokinetics and Efficacy (29 papers) and Pharmacogenetics and Drug Metabolism (25 papers). Jeffrey S. Barrett is often cited by papers focused on Pharmaceutical studies and practices (46 papers), Antibiotics Pharmacokinetics and Efficacy (29 papers) and Pharmacogenetics and Drug Metabolism (25 papers). Jeffrey S. Barrett collaborates with scholars based in United States, United Kingdom and Germany. Jeffrey S. Barrett's co-authors include Bernd Meibohm, Peter C. Adamson, Stephanie Läer, Bhuvana Jayaraman, Jeffrey Skolnik, Mahesh Narayan, Di Wu, Michael J. Fossler, Daniel K. Benjamin and Marc R. Gastonguay and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jeffrey S. Barrett

186 papers receiving 4.8k citations

Peers

Countries citing papers authored by Jeffrey S. Barrett

Since Specialization

Citations

This map shows the geographic impact of Jeffrey S. Barrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey S. Barrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey S. Barrett more than expected).

Fields of papers citing papers by Jeffrey S. Barrett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey S. Barrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey S. Barrett. The network helps show where Jeffrey S. Barrett may publish in the future.

Co-authorship network of co-authors of Jeffrey S. Barrett

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey S. Barrett. A scholar is included among the top collaborators of Jeffrey S. Barrett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey S. Barrett. Jeffrey S. Barrett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Consideration of the Root Causes in Candidate Attrition During Oncology Drug Development 2024 ·Clinical Pharmacology in Drug Development ·Yin‐Ming Kuo, Jeffrey S. Barrett	2
2	Supporting Prospective Pregnancy Trials via Modeling and Simulation: Lessons From the Past and Recommendations for the Future 2023 ·The Journal of Clinical Pharmacology ·S. Y. Amy Cheung, Jeffrey S. Barrett	1
3	History and Future Perspectives on the Discipline of Quantitative Systems Pharmacology Modeling and Its Applications 2021 ·Frontiers in Physiology ·Karim Azer, Chanchala Kaddi, Jeffrey S. Barrett, Jane P. F. Bai, Sean T. McQuade, (unknown), Benedetto Piccoli, Susana R. Neves, Luca Marchetti, (unknown), Silvia Parolo, (unknown), Nitin S. Baliga	62
4	Challenges and considerations for development of therapeutic proteins in pediatric patients 2015 ·The Journal of Clinical Pharmacology ·Yi Zhang, Xiaohui Wei, Gaurav Bajaj, Jeffrey S. Barrett, Bernd Meibohm, Amita Joshi, Manish Gupta	25
5	ABCB1 Polymorphism and Gender Affect the Pharmacokinetics of Amlodipine in Chinese Patients with Essential Hypertension: A Population Analysis 2014 ·Drug Metabolism and Pharmacokinetics ·Xiao‐cong Zuo, Wenli Zhang, Hong Yuan, Jeffrey S. Barrett, Hua Ye, Zhijun Huang, Hong‐Hao Zhou, Qi Pei, Chengxian Guo, Jianglin Wang, Guoping Yang	17
6	Busulfan in Infant to Adult Hematopoietic Cell Transplant Recipients: A Population Pharmacokinetic Model for Initial and Bayesian Dose Personalization 2013 ·Clinical Cancer Research ·Jeannine S. McCune, Meagan J. Bemer, Jeffrey S. Barrett, K. Scott Baker, Alan S. Gamis, Nicholas H. G. Holford	110
7	Considerations for the prediction of survival time in pancreatic cancer based on registry data 2013 ·Journal of Pharmacokinetics and Pharmacodynamics ·Gaurav Bajaj, (unknown), Qilu Yu, Banke Agarwal, Jeffrey S. Barrett	1
8	Population Pharmacokinetics of Valproic Acid in Pediatric Patients With Epilepsy: Considerations for Dosing Spinal Muscular Atrophy Patients 2011 ·The Journal of Clinical Pharmacology ·Jason H. Williams, (unknown), Kathryn J. Swoboda, Jeffrey S. Barrett	22
9	Population Pharmacokinetics of Pentobarbital in Neonates, Infants, and Children after Open Heart Surgery 2011 ·The Journal of Pediatrics ·Athena F. Zuppa, Susan C. Nicolson, Jeffrey S. Barrett, Marc R. Gastonguay	9
10	Fluconazole Dosing for the Prevention or Treatment of Invasive Candidiasis in Young Infants 2009 ·The Pediatric Infectious Disease Journal ·Kelly C. Wade, Daniel K. Benjamin, David Kaufman, Robert M. Ward, Phillip Brian Smith, Bhuvana Jayaraman, Peter C. Adamson, Marc R. Gastonguay, Jeffrey S. Barrett	80
11	Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children’s oncology group 2008 ·Cancer Chemotherapy and Pharmacology ·Patrick A. Thompson, Manish Gupta, Gary L. Rosner, Alexander Yu, Jeffrey S. Barrett, Lisa Bomgaars, Mark L. Bernstein, Susan M. Blaney, John Mondick	21
12	Integration of modeling and simulation into hospital-based decision support systems guiding pediatric pharmacotherapy 2008 ·BMC Medical Informatics and Decision Making ·Jeffrey S. Barrett, John Mondick, Mahesh Narayan, (unknown), (unknown)	54
13	Globalization of Quantitative Pharmacology: First International Symposium of Quantitative Pharmacology in Drug Development and Regulation 2008 ·The Journal of Clinical Pharmacology ·Jeffrey S. Barrett, (unknown), Haitang Xie, Xiaohui Huang, Michael J. Fossler, (unknown)	1
14	A SAS-based solution to evaluate study design efficiency of phase I pediatric oncology trials via discrete event simulation 2008 ·Computer Methods and Programs in Biomedicine ·Jeffrey S. Barrett, Bhuvana Jayaraman, Dimple Patel, Jeffrey Skolnik	10
15	Clinical and Pharmacokinetic Characteristics of Intracavitary Administration of Pegylated Liposomal Encapsulated Doxorubicin in Dogs with Splenic Hemangiosarcoma 2007 ·Journal of Veterinary Internal Medicine ·Karin U. Sørenmo, (unknown), Craig A. Clifford, Jennifer Baez, Jeffrey S. Barrett, Robert H. Poppenga, Beth Overley, Katherine A. Skorupski, (unknown), Tom Van Winkle, (unknown), Frances S. Shofer	24
16	Analysis and comparison of active constituents in commercial standardized silymarin extracts by liquid chromatography–electrospray ionization mass spectrometry 2006 ·Journal of Chromatography B ·(unknown), Mahesh Narayan, Jeffrey S. Barrett	86
17	Population pharmacokinetic studies in pediatrics: Issues in design and analysis 2005 ·The AAPS Journal ·Bernd Meibohm, Stephanie Läer, John C. Panetta, Jeffrey S. Barrett	137
18	Pharmacokinetics and Safety of the Ketolide Telithromycin in Patients with Renal Impairment 2004 ·The Journal of Clinical Pharmacology ·Jun Yi Shi, Guy Montay, Sunny Chapel, Pierre Hardy, Jeffrey S. Barrett, Marshall Sack, Thomas Marbury, Suzanne K. Swan, Ramón Vargas, V. Leclerc, Bruno Leroy, Vijay O. Bhargava	32
19	Update to the PhRMA Perspective on Population and Individual Bioequivalence 2000 ·The Journal of Clinical Pharmacology ·Jeffrey S. Barrett, Vijay Batra, Andrew Chow, Jack Cook, A. Lawrence Gould, Allen H. Heller, Man‐Wai Lo, Scott D. Patterson, Brian P. Smith, (unknown), José M. Vega, Névine Zariffa	5
20	Disposition and exposure of the fibrinogen receptor antagonist XV459 on αIIBβ3 binding sites in the guinea pig 1999 ·Biopharmaceutics & Drug Disposition ·Jeffrey S. Barrett, Jun Yu, Ram P. Kapil, (unknown), Foster Brown, William F. Ebling, Martha H. Corjay, Thomas M. Reilly, Jeffrey M. Bozarth, Shaker A. Mousa, Henry J. Pieniaszek	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact